FragMAX awarded funding from the Swedish Research council
Published 29 March 2019 FragMAX, a project run in collaboration between LP3, MAXIV, Astra Zeneca and SARomics Biostructures, has been awarded funding from the Swedish Research Council. The project aims to establish a fragment based screening facility, enabling scientists and small companies to screen low molecular weight fragments for binding to target proteins using X-ray crystallography.Read mor
https://www.lp3.lu.se/article/fragmax-awarded-funding-swedish-research-council - 2025-04-27